Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients

Postprandial hypertriglyceridemia is considered as a risk factor for cardiovascular disease in Type 2 diabetes. However, little is known about the underlying mechanisms. Since the recently discovered apolipoprotein (apo) AV was identified as a modulator of triglyceride (TG) metabolism, the aim of th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 2005-08, Vol.181 (2), p.403-405
Hauptverfasser:	Pruneta-Deloche, Valérie, Ponsin, Gabriel, Groisne, Laure, Fruchart-Najib, Jamila, Lagarde, Michel, Moulin, Philippe
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Apolipoprotein A-V Apolipoprotein AV Apolipoproteins - blood Apolipoproteins A Associated diseases and complications Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular system Diabetes Mellitus, Type 2 - blood Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Humans Hypertriglyceridemia - blood Lipolysis Lipolysis - physiology Male Medical sciences Middle Aged Pharmacology. Drug treatments Postprandial lipemia Postprandial Period - physiology Triglycerides - blood Type 2 diabetes Vasodilator agents. Cerebral vasodilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!